Literature DB >> 3370191

Saturation of the tubular excretion of beta-lactam antibiotics.

J W Bins1, H Mattie.   

Abstract

1 The saturability of the tubular excretion of cloxacillin, benzylpenicillin and cephradine was investigated. 2 Volunteers received a continuous infusion of one of the antibiotics at increasing infusion rates in order to maintain constant plasma concentrations at three different levels. Blood and urine samples were taken every 30 min. Sufficient urinary flow was ensured by a saline infusion (500 ml h-1). 3 Renal clearance of the antibiotic was calculated for the non-protein bound fraction of the drug. 4 Tubular clearance and tubular excretion rate were estimated by using the renal clearance of the antibiotic minus the glomerular filtration rate; the latter was considered to be equal to creatinine clearance. 5 Data were fitted to a Scatchard transformation and, by nonlinear methods, to a Michaelis-Menten equation. 6 Parameters of saturability, i.e. EC50 and maximal tubular excretion rate, were established. The values found for EC50 were 7.7, 93.0 and 266 mg l-1 for cloxacillin, benzylpenicillin and cephradine, respectively. The values calculated for the maximal tubular excretion rate were 1017, 5535 and 4537 mg h-1, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3370191      PMCID: PMC1386613          DOI: 10.1111/j.1365-2125.1988.tb03280.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  [PHARMACOKINETICS OF PENICILLIN G IN CONVENTIONAL AND EXTREMELY HIGH DOSAGE].

Authors:  G HITZENBERGER; K H SPITZY
Journal:  Arzneimittelforschung       Date:  1964-01

2.  The kinetics of alcohol elimination in man.

Authors:  F LUNDQUIST; H WOLTHERS
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1958

3.  Penicillin clearance as kidney function test, determinations with and without collection of urine.

Authors:  M PERS
Journal:  Scand J Clin Lab Invest       Date:  1954       Impact factor: 1.713

4.  THE ABSORPTION AND EXCRETION OF PENICILLIN FOLLOWING CONTINUOUS INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION.

Authors:  L A Rantz; W M Kirby; E Randall
Journal:  J Clin Invest       Date:  1944-09       Impact factor: 14.808

5.  THE RENAL CLEARANCE OF PENICILLINS F, G, K, AND X IN RABBITS AND MAN.

Authors:  H Eagle; E Newman; A D Musselman; M Robinson; M Birmingham
Journal:  J Clin Invest       Date:  1947-09       Impact factor: 14.808

6.  THE ABSORPTION, EXCRETION, AND DISTRIBUTION OF PENICILLIN.

Authors:  C H Rammelkamp; C S Keefer
Journal:  J Clin Invest       Date:  1943-05       Impact factor: 14.808

7.  Transport and toxicity of cephaloridine in the kidney. Effect of furosemide, p-aminohippurate and saline diuresis.

Authors:  B M Tune; K Y Wu; D F Longerbeam; R L Kempson
Journal:  J Pharmacol Exp Ther       Date:  1977-08       Impact factor: 4.030

8.  Piperacillin: human pharmacokinetics after intravenous and intramuscular administration.

Authors:  T B Tjandramaga; A Mullie; R Verbesselt; P J De Schepper; L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

9.  Pharmacokinetics of azlocillin in children with cystic fibrosis.

Authors:  T Bergan; H Michalsen
Journal:  Arzneimittelforschung       Date:  1979

10.  Renal excretion of cephapirin and cephaloridine: evidence for saturable tubular reabsorption.

Authors:  A Arvidsson; O Borgå; G Alván
Journal:  Clin Pharmacol Ther       Date:  1979-06       Impact factor: 6.875

View more
  12 in total

Review 1.  Saturable pharmacokinetics in the renal excretion of drugs.

Authors:  C A van Ginneken; F G Russel
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

2.  Analysis of the pharmacokinetic interaction between cephalexin and quinapril by a nonlinear mixed-effect model.

Authors:  C Padoin; M Tod; G Perret; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

3.  The tubular excretion of benzylpenicillin in patients with cystic fibrosis.

Authors:  J W Bins; H Mattie
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

4.  The effect of probenecid on the renal tubular excretion of benzylpenicillin.

Authors:  D Overbosch; C Van Gulpen; J Hermans; H Mattie
Journal:  Br J Clin Pharmacol       Date:  1988-01       Impact factor: 4.335

5.  Levels of azithromycin and alpha-1 acid glycoprotein in serum in patients with community-acquired pneumonia.

Authors:  R Bohte; H Mattie; P J van den Broek
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

6.  The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion.

Authors:  C A Verhagen; H Mattie; E Van Strijen
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

7.  Pharmacokinetic interaction between cefdinir and two angiotensin-converting enzyme inhibitors in rats.

Authors:  A Jacolot; M Tod; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

Review 8.  Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions.

Authors:  D J Touw; A A Vinks; J W Mouton; A M Horrevorts
Journal:  Clin Pharmacokinet       Date:  1998-12       Impact factor: 6.447

9.  Transport of beta-lactam antibiotics in kidney brush border membrane. Determinants of their affinity for the oligopeptide/H+ symporter.

Authors:  H Daniel; S A Adibi
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Influence of the unbound concentration of cefonicid on its renal elimination in isolated perfused rat kidneys.

Authors:  C A Rodriguez; D E Smith
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.